Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

NanoBio gets $10mm in first close of $30mm financing

Executive Summary

NanoBio (uses nano-emulsion technology to develop vaccines and topical compounds for infectious diseases) raised $10mm in the first of a three-tranche private financing to Perseus LLC that will help support the company's clinical-stage compounds. NanoBio expects to bring in the remaining $20mm, which is contingent upon the achievement of developmental milestones, over the next two years.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
      • Topical Delivery
  • Biotechnology
    • Drug Discovery Tools
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies